Nitric Oxide Deficiency in Fenfluramine- and Dexfenfluramine-induced Pulmonary Hypertension-Reference-Cited by-同舟云学术

Nitric Oxide Deficiency in Fenfluramine- and Dexfenfluramine-induced Pulmonary Hypertension

Published:1998-10 Issue:4 Volume:158 Page:1061-1067
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

ARCHER STEPHEN L.,DJABALLAH KHIER,HUMBERT MARC,KENNETH WEIR E.,FARTOUKH MURIEL,DALL'AVA-SANTUCCI JOSETTE,MERCIER JEAN-CHRISTOPHE,SIMONNEAU GERALD,TUAN DINH-XUAN A.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference27 articles.

1. PREVALENCE OF OBESITY

2. Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension

3. Fatal Pulmonary Hypertension Associated with Short-Term Use of Fenfluramine and Phentermine

4. Anorexic Agents Aminorex, Fenfluramine, and Dexfenfluramine Inhibit Potassium Current in Rat Pulmonary Vascular Smooth Muscle and Cause Pulmonary Vasoconstriction

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding pulmonary hypertension: the need for an integrative metabolomics and transcriptomics approach;Molecular Omics;2024

2. Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding;Neuropsychiatric Disease and Treatment;2023-09

3. Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis;Frontiers in Pharmacology;2023-01-26

4. Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases;Therapeutic Advances in Chronic Disease;2023-01

5. Evaluating Riociguat in the Treatment of Pulmonary Arterial Hypertension: A Real-World Perspective;Vascular Health and Risk Management;2022-10